14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Mon, 20 May 2024

Trading levels for ITCI

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 67.56 3.94 %
R2 66.81 2.79 %
R1 66.35 2.07 %
Current price: 65.00
Support S1 64.85 -0.229 %
S2 64.39 -0.94 %
S3 63.64 -2.09 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 79.84 22.83 %
R2 76.69 17.98 %
R1 72.00 10.77 %
Current price 65.00
Support S1 64.96 -0.0615%
S2 64.78 -0.338%
S3 64.57 -0.662%

ITCI Predictions History

4 years ago
dishang patel predicted that ITCI for 2019-12-26 is going

Rank:

5 years ago
GoldenNugget predicted that ITCI for 2019-05-07 is going $14.25 (0.56%)

5 years ago
GoldenNugget predicted that ITCI for 2019-05-06 is going $13.55 (-5.20%)

5 years ago
NameNotImportant predicted that ITCI for 2019-05-02 is going $13.57 (0.44%)

5 years ago
NameNotImportant predicted that ITCI for 2019-04-29 is going $13.78 (0.95%)

5 years ago
NameNotImportant predicted that ITCI for 2019-04-24 is going $12.38 (-5.35%)

7 years ago
Abdu predicted that ITCI for 2016-12-12 is going $15.44 (-0.39%)

7 years ago
JS predicted that ITCI for 2016-05-24 is going $37.13 (1.06%)

Click to get the best stock tips daily for free!

About Intra-Cellular Therapies Inc.

Intra-Cellular Therapies. Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in developing lumateperone, which is in Phase III clinical trial for the treatment of bipolar depression, as ... ITCI Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT